Immediate breast reconstructions after mastectomy due to breast cancers with the use of Serasynth and SeragynBR synthetic meshes. Single-oncological center experience, analysis of complications

Abstract

PurposeThe use of meshes in mastectomies with immediate breast reconstruction (IBR) has become a gold standard. The purpose of the study was to analyze the complications and own experience with the use of Serasynth fully absorbable and SeragynBR partialy absorbable synthetic meshes. MethodsIn the period from December 2017 to July 2020, 118 IBR were performed in the Author’s Department with the use of SeragynBR and Serasynth meshes in 93 patients operated for breast cancer. 78 Serasynth meshes (Group1) and 40 SeragynBR meshes (Group1I) were implanted. ResultsThe most common complication was persistent seroma collection, which was reported in 17.9% of cases in Group1 and 25% in Group2. Skin inflammation was reported in 7.6% and 17.5%, while infections in 2.5% and 5% of the operated breasts in Group1 and Group2. Reoperation was required in 5.1% and 5% of the patients in Group1 and Group2. The percentage of complications was lower when Serasynth rather than Seragyn BR meshes were implanted. The frequent incidence of the seroma collection did not contribute in any significant way to serious complications such as removal of mesh/implant or infection. The complications, which developed following the implantation of both mesh types, were similar to those presented in other publications concerning mastectomy with IBR with the use of synthetic meshes. The percentage of implant losses/explanations in the discussed groups was lower than that reported in literature.ConclusionDespite the complications, both types of meshes can be considered as safe additions to reconstructive breast surgeries.